Small Molecules
17 June 2013
Incyte Drug Jakafi (ruxolitinib) Improved Overall Survival in Phase III Trial of Patients with Myelofibrosis13 June 2013
Epizyme Enrolls First Patient in Phase 1/2 Clinical Trial of EPZ-6438, an Inhibitor of EZH213 June 2013
PRISM Pharma Closes $15 million Series C Financing to Advance PRI-724 into Non-oncology Indications12 June 2013
TOPICA Announces Completion of Enrollment in Its Phase 2b/3 Onychomycosis Trial of 10% Luliconazole SolutionNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports